Publication not explained
Read the Original
This page is a summary of: PO-0659: Hypofractionated-accelerated concomitant boost in moderate-high risk breast cancer:phase I-II study, Radiotherapy and Oncology, May 2017, Elsevier, DOI: 10.1016/s0167-8140(17)31096-4.
You can read the full text:
Be the first to contribute to this page